Elicio Therapeutics, Inc. (ELTX)
(Delayed Data from NSDQ)
$9.20 USD
+0.13 (1.43%)
Updated Aug 8, 2025 04:00 PM ET
After-Market: $9.19 -0.01 (-0.11%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth B Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Elicio Therapeutics, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
ELTX 9.20 +0.13(1.43%)
Will ELTX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ELTX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ELTX
Here's Why Elicio Therapeutics (ELTX) Could be Great Choice for a Bottom Fisher
Is Elicio Therapeutics, Inc. (ELTX) Stock Outpacing Its Medical Peers This Year?
ELTX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Elicio Therapeutics (ELTX) Upgraded to Buy: Here's What You Should Know
All You Need to Know About Elicio Therapeutics (ELTX) Rating Upgrade to Strong Buy
Other News for ELTX
Elicio Therapeutics GAAP EPS of -$0.66
JonesTrading Sticks to Their Buy Rating for Elicio Therapeutics (ELTX)
Elicio Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate ...
Elicio Therapeutics (ELTX) Advances with Positive Interim Trial Review
Elicio announces positive recommendation by IDMC to continue ELI-002 Phase 2